With advances in pediatric cardiac surgery, there have been major improvements in the survival of children born with congenital heart disease (CHD). As a consequence, there is a growing population of young women with CHD, the majority of whom will become pregnant. However, for women with CHD, pregnancy imposes a hemodynamic stress on the heart and this can result in pregnancy complications for women and their babies. Although there have been a large number of studies examining adverse pregnancy outcomes in women with CHD, some important questions remain unanswered. For instance, the true maternal mortality risk in women with CHD is not known. This is in part because maternal deaths are rare, few large cohorts are available and because there can be a survivor bias in published series. Rates of maternal cardiac complications, such as arrhythmias or heart failure, are also frequently biased as studies often include women followed in tertiary or quaternary referral centres and not those women followed in smaller hospitals. The impact of CHD on other aspects of care such as length of stay or hospital costs is rarely reported, but is important consideration for women, their families and hospital administrators. The study by Opotowsky et al. 1 examines the epidemiology of cardiovascular events at the time of delivery in women with CHD and addresses many of these unanswered questions.
failure are the main complications that occur in this population and, although rare, maternal mortality is increased when compared to women without CHD. Women with complex cardiac lesions and pulmonary hypertension are at particularly high risk for adverse outcomes and these are important considerations during preconception counseling. Despite advances in medical therapies, severe pulmonary hypertension from any cause still carries a high mortality risk and pregnancy is contraindicated. 4, 5 While lesion complexity and pulmonary hypertension are risk factors for adverse outcomes at the time of delivery, there are a number of additional risk factors that can also help to identify women at risk and these should also should be integrated into risk assessment. 6, 7 In addition to maternal morbidity and mortality, other aspects of care such as length of stay and hospital costs are also increased in women with CHD, particularly in those women who develop complications at the time of delivery. Obstetric care also differs in women with CHD. Current recommendations suggest that vaginal delivery can be safely undertaken by most women with CHD. 8, 9 However, Caesarean deliveries which are known to be associated with higher complications rates when compared to vaginal deliveries, are more common in this group of women. The reasons for increased Caesarean deliveries in women with CHD is not explained by this study, but may reflect concern of health care providers to allow women with CHD to undergo a vaginal delivery. Further education of health care providers may be required.
Some maternal complications may be preventable. The most recent report of the Confidential Inquiries into Maternal Mortality in the United Kingdom concluded that a substantial portion of maternal cardiac deaths in pregnancy were related to substandard delivery of care. 10 Care of pregnant woman with CHD is complex, requiring a multidisciplinary team of cardiologists, high-risk obstetricians, obstetric anesthesiologists, neonatologists, and nurses. Efforts to improve coordination of care and delivery of care are potential targets for quality and safety initiatives that may ultimately help to decrease adverse event rates or shorten length of stay.
